GDNF and amyotrophic lateral sclerosis: On the contrary, systemic injection of AAV9-GDNF to young rats, in a model of ALS, did not increase lifespan; even though AAV9-GDNF injection resulted in modest functional improvement, important sides effects related to systemic injection (i.e., slower weight gain, reduced activity levels and decreased working memory) were observed [74].